Sinopharm is the first Chinese shot to be classified as safe and effective by the World Health Organization, allowing the vaccine to be more widely distributed to poor and middle-income nations.
Tag: Sinovac Biotech Ltd
China’s Sinopharm Vaccine Approved for Emergency Use By W.H.O.
The World Health Organization has approved a Chinese vaccine for emergency use. The announcement comes at a time when officials in the country are warning of a domestic shortage.
My Family’s Global Vaccine Journey
We were spread across three continents, at the mercy of vaccine geopolitics. Which of us would be inoculated last?
Brazil Needs Coronavirus Vaccines. China Is Benefiting.
China is a major supplier of coronavirus vaccine, giving it enormous leverage in pandemic-ravaged nations. Brazil, recently hostile to the Chinese company Huawei, has suddenly changed its stance.
Ukraine Blames Lagging Covid Vaccinations on Misinformation
Opened vials of vaccine at hospitals have gone to waste when doctors and nurses declined shots, news media have reported. In a country of 42 million, just over 23,000 people have received a dose.
China Wanted to Show Off Its Vaccines. It’s Backfiring.
Delays, inconsistent data, spotty disclosures and the country’s attacks on Western rivals have marred its ambitious effort to portray itself as a leader in global health.
Bolsonaro Talked Vaccines Down. Now Brazil has Too Few Doses.
The country is paying a price for its leader’s slow pursuit of coronavirus vaccines early on. That lapse may hinder Brazil’s ability to fight worrisome variants as cases surge.
Disappointing Chinese Vaccine Results Pose Setback for Developing World
Brazil says CoronaVac has an efficacy rate just over 50 percent, much lower than previously announced. More than 380 million doses have already been ordered.
Your Friday Briefing
A wounded U.S. in turmoil
Covid Vaccine Made by Chinese Company Sinovac Is Said to Be Effective
Sinovac Biotech has sold more than 300 million doses to the developing world, filling a gap left by Western countries.